Efficacy of Durvalumab‐Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study
Continued Dur/Tre therapy may be effective in patients with improved NLR and DCP levels after adjunct locoregional therapy. Further studies involving larger patient cohort might determine strategic addition of locoregional therapy in PD.
Authors
- Ryo Sato (ORCID: https://orcid.org/0000-0002-1340-4739)
- Junji Yokoyama (ORCID: https://orcid.org/0000-0002-1810-7709)
- Takahiro Iwasawa
- Toshifumi Sato
- Masahiro Ogawa (ORCID: https://orcid.org/0000-0003-2154-7999)
- Yuji Kobayashi
- Terasu Honma
- Toru Ishikawa
- HIROKI NATSUI
Institutions
- Saiseikai Niigata Daini Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.21873/cdp.10473
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00